Phase Ib trial of APD 811 in volunteers.
Phase of Trial: Phase I
Latest Information Update: 24 May 2017
At a glance
- Drugs Ralinepag (Primary)
- Indications Pulmonary hypertension
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Arena Pharmaceuticals
- 24 May 2017 Results (n=50) presented at the 113th International Conference of the American Thoracic Society
- 16 May 2017 According to an Arena Pharmaceuticals media release, data from this trial will be presented at the American Thoracic Society (ATS) 2017 International Conference.
- 14 Apr 2014 New trial record